Forbes - ONCONASE is currently being evaluated as a treatment for unresectable malignant mesothelioma (UMM) in a confirmatory Phase IIIb clinical trial. Under the terms of the agreement, Strativa will have exclusive marketing, sales and distribution rights to ...